Chronic obstructive pulmonary disease (COPD) is predicted to become the third leading cause of death worldwide by 2020 [1] . COPD is characterized by development of irreversible airflow limitation and destruction of alveolar septa, resulting in alveolar enlargement and airway obstruction. Although smoking is the primary risk factor for COPD, only 15%-20% of smok-
cofactor in HIV-related COPD pathogenesis, we developed a Pc colonization model using chimeric simian/human immunodeficiency virus (SHIV) in macaques. Excellent rationale for the use of this model exists, because studies have shown that Pc derived from humans and nonhuman primates is most closely related phylogenetically [10, 11] . We performed longitudinal studies to determine the association between Pc colonization and progression of airway obstruction and emphysema in the context of an AIDS model.
METHODS

Animals. Twelve adult cynomolgus macaques (Macaca fasicularis)
of Chinese origin were obtained from national primate centers or from vendors approved by the Department of Laboratory Animal Research, University of Pittsburgh, and were individually housed and maintained in a biosafety level 2+ primate facility at the University of Pittsburgh. Before purchase, all animals were screened and found to be negative for simian retroviral infections. Animal experiments were approved by the institutional animal care and use committee at the University of Pittsburgh. Clinical evaluations were conducted monthly or as needed [12] .
Virus infection. Monkeys were infected, as described elsewhere [13] , with SHIV 89.6P (a gift of Opendra Narayan, University of Kansas), which induces CD4 + T cell lymphopenia and AIDS-like disease with wasting and opportunistic infections [13, 14] . Inoculations were repeated one month later, to ensure infection in all animals. Viral loads were determined as described for blood and bronchoalveolar lavage (BAL) samples [13] .
BAL. Monkeys underwent BAL at baseline and at monthly intervals after SHIV infection [12] . Unfractionated BAL fluid (BALF) aliquots were used for bacterial, fungal, and viral culture (Antech Diagnostics) and nested polymerase chain reaction (PCR) detection of Pc DNA [12] . After the remainder was filtered through a 40-micron cell strainer, cell counts were performed, and supernatants were used for cytokine analysis and quantitation of SHIV [13] . A total of cells were removed 5 1 ϫ 10 and stained with modified Giemsa stain (Dade Behring), and differential counts were performed manually [15] . Recovered cells were prepared for flow cytometry, as described elsewhere [12] .
Pc colonization of SHIV-infected macaques. To promote natural transmission of Pc, SHIV-infected macaques were continuously exposed by cohousing in the same room with 10-20 simian immunodeficiency virus (SIV)-or SHIV-immunosuppressed macaques that served as a Pc source. None of the macaques (source or recipient macaques) contracted fulminate Pc pneumonia (PcP) during the study. Determination of Pc colonization status was performed by detection of Pc DNA in BAL samples, by use of nested PCR and by anti-Pc serologic testing [12, 16] . Pc colonization was defined as a positive result of nested PCR of BALF and a 13-fold change in plasma anti-Pc KEX1 titers [16] . In addition, BALF samples were stained for organisms by means of modified Giemsa and silver staining [12] .
Peripheral blood collection. Peripheral blood was collected and processed as described elsewhere [13] . T cells were analyzed as described elsewhere [16] .
Cytokine and chemokine analysis. Quantitative analysis of cytokines and chemokines in BALF was performed using the Beadlyte Human Multi-Cytokine Flex Kit (Upstate), in accordance with the instructions of the manufacturer. Thirteen of the analytes shown in Table 1 were chosen based on crossreactivity with nonhuman primate proteins [17] . Levels of interleukin (IL)-10 and IL-13 were analyzed using monkey-specific enzyme-linked immunosorbent assay kits (BioSource and Cell Sciences, respectively). The dilution effect for BALF samples was normalized based on plasma urea concentrations [18] .
Pulmonary function testing. Pulmonary function tests were performed at baseline and every other month after SHIV infection, by use of whole-body plethysmography and forced deflation technique. Monkeys were anesthetized with intravenous propofol, and the oropharynx was desensitized with 2% lidocaine followed by intubation. Endotracheal tube placement was verified by chest radiography and monitored using a carbon dioxide detector (Nellcor Pedi-cap). Pulmonary function tests were performed using a Buxco whole-body plethysmograph (Buxco Electronics), and BioSystems for Maneuvers Software (Buxco Electronics) was used to collect data on flow rates and flow volumes. Tests were considered to be valid when 3 measurements for forced vital capacity were within 10% of each other.
For bronchodilator challenge, standard pulmonary function tests were performed, followed by administration of 1 pediatric dosette of nebulized albuterol (3 mL of 0.083% albuterol; Nephron Pharmaceuticals). At 15 min after administration, pulmonary function tests were repeated, and results were compared with baseline values.
Quantitative computed tomography. Conventional, noncontrast computed tomography was performed for 10 of the 12 animals in a GE 9800 Highlight Advantage computed tomography scanner (General Electric Medical Systems). Anesthetized intubated animals were mechanically ventilated to 20 cm of H 2 O, to ensure scan-to-scan volume uniformity. Axial slices (1.25 mm) were acquired during end-inspiratory breath hold. Calculation of densities used in the determination of lung properties presented in Table 2 was performed for animals at baseline and was repeated after SHIV infection, as described elsewhere [19] . In brief, mean computed tomography scan attenuations of the lung were calculated and converted to density measurements expressed in milligrams per milliliter, which was NOTE. BL, baseline; GM-CSF, granulocyte-macrophage-colony-stimulating factor; IFN, interferon; IL, interleukin; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor. Pneumocystis (Pc) colonization was detected by 8 weeks after SHIV infection.
a P values, analyzed by paired t test, are for measurements performed at baseline versus measurements obtained at the indicated week after SHIV infection in SHIV/Pc-positive ( ) and SHIV/ n p 8 Pc-negative ( ) animals. Time points where significant changes in cytokine levels were detected n p 4 are shown in italics.
then multiplied by lung volume to obtain lung mass approximation. Actual lung weights measured at necropsy correlated with lung weights calculated from end point scans, by Pearson correlation analysis ( ). Computed tomography analy-P p .01 sis was performed in a blinded manner with the use of custom software (EmphylxJ; Department of Radiology/iCAPTURE Laboratory, University of British Columbia, Vancouver, British Columbia, Canada) [20] . Small-airway dimensions were also calculated using EmphylxJ software [21] .
Lung tissue preparation and morphometry. Right lungs removed at necropsy were inflated to 25 cm H 2 O with 10% buffered formalin. Paraffin-embedded, serial midsagittal sections from each lobe were then stained. Modified Harris hematoxylin-stained (Sigma) tissue was used to estimate alveolar size by determination of mean chord lengths [22] . Hematoxylin-eosin-stained tissue sections were examined for the presence of bronchial-associated lymphoid tissue, as defined by the presence of nonencapsulated lymphoid tissue within outer airway walls. Approximately 100 airways per monkey were examined.
Statistical analysis. Pulmonary function data analysis was performed using the R environment, for statistical analysis, and graphics in which mixed linear models were used to estimate and test the relationship among pulmonary function profiles (dependent variable), Pc colonization (independent variable), and time (independent variable). Differences in profiles over time were tested using restricted maximum likelihood. All other data were analyzed using Prism software (GraphPad) with + T cell levels in simian/ human immunodeficiency virus (SHIV)/Pneumocystis (Pc)-positive animals versus SHIV/Pc-negative animals. Peripheral blood mononuclear cells isolated from whole blood were stained with anti-CD4 antibody and analyzed by flow cytometry. Open circles denote SHIV/Pc-positive animals, and closed squares denote SHIV/Pc-negative animals.
, by 2-way re-P p .79 peated measures analysis of variance for the SHIV/Pc-positive group ( ) versus the SHIV/Pc-negative group ( ). n p 8 n p 4 paired or unpaired, 2-tailed Student's t test, where appropriate. was considered to denote statistical significance. P ! .05
RESULTS
Pneumocystis colonization of SHIV-infected macaques results
in pulmonary obstruction. Twelve cynomolgus macaques were infected with SHIV 89.6P [14] and exposed to Pc via cohousing with Pc-infected macaques [16] . Peripheral blood CD4 + T cell levels decreased to р50% of baseline values by 4 weeks after SHIV infection in all monkeys, and they remained depressed throughout the study (Figure 1 ). Peak viremia ranged from to RNA copies/mL by week 2 after 6 8 3.4 ϫ 10 2.3 ϫ 10 infection (not shown). Serial bacterial and fungal cultures of BALF had negative results throughout the study. Eight of 12 monkeys became colonized with Pc by 9 weeks after SHIV infection (SHIV/Pc positive), as determined by nested PCR of BALF and Pc serologic testing [16] , whereas 4 remained Pc negative throughout the study (SHIV/Pc negative). After initial exposure to Pc, anti-Pc titers in the SHIV/Pc-positive animals remained above baseline throughout the study (not shown). None of the monkeys had positive PCR results at every time point, which was most likely the result of the low-level organism burden and sampling of different areas of the lung at each time point. Among these animals, positive PCR results were noted at 2-9 time points during the period studied. Modified Giemsa staining and silver staining were also performed on BAL samples, but the samples were not found to be positive for organisms at any time point. There was no significant difference in mean ‫ע(‬ standard deviation [SD]) peak viral titers (for SHIV/ Pc-positive animals, ‫ע‬ viral RNA cop- 7 7 4.42 ϫ 10 7.50 ϫ 10 ies/mL plasma; for SHIV/Pc-negative animals, ‫ע‬ To assess airway obstruction, pulmonary maneuvers using whole-body plethysmography [23] were performed at baseline and every other month after SHIV infection. Peak expiratory flow, forced expiratory volume in 0.4 s, and maximum midexpiratory flow are the pulmonary function parameters chosen to evaluate obstructive disease. No significant differences in the physical characteristics and pulmonary function parameters between groups were observed at baseline (Table 3) . Six of 8 SHIV/Pc-positive animals developed airway obstruction, as determined by evidence of decreased pulmonary function. All parameters that were evaluated decreased significantly in these animals, compared with SHIV/Pc-negative monkeys (Figure 2A-C) . The median change in peak expiratory flow from baseline to 10 months after SHIV infection was Ϫ58.5 mL/s and +2.5 mL/s for SHIV/Pc-positive and SHIV/Pc-negative animals, respectively ( ). The median change from P p .004 the baseline forced expiratory volume in 0.4 s was Ϫ16.0 mL in SHIV/Pc-positive animals versus +4.0 mL in SHIV/Pc-negative animals ( ). For maximum midexpiratory flow, P p .001 the median change from baseline was -47.5 mL/s for SHIV/ Pc-positive animals versus +24.5 mL/s for SHIV/Pc-negative monkeys ( ). Although the ratio of forced expiratory P p .001 volume in 0.4 s to forced vital capacity-another measurement of COPD-decreased in SHIV/Pc-positive animals, the change was not significant by 10 months after infection ( Figure 2D ).
Because airflow limitation in COPD is poorly reversible in response to bronchodilator treatment, we tested the effect of administration of the bronchodilator albuterol. No significant differences were observed after treatment (not shown).
Pc colonization results in radiographic and pulmonary emphysema, but not small airway thickening, in SHIV-infected monkeys. Emphysema is associated with increased lung and airspace volumes, usually coupled with decreased lung weight. Quantitative computed tomography morphometry has been used to evaluate the extent of emphysema in humans [19] . We applied this technique to evaluate lung computed tomography scans obtained at baseline and after infection by performing tissue density analysis based on a density mask cutoff value of рϪ910 Hounsfield units (HU), which is similarly used to identify emphysema in humans [19] . Compared with baseline values, there was a significant increase in the lung percentage at рϪ910 HU in SHIV/Pc-positive monkeys, compared with SHIV/Pc-negative monkeys ( Figure 3A) . Lobe-by-lobe comparison of the percentage change in рϪ910 HU during the course of infection revealed significant increases in the upper and middle lobes of SHIV/Pc-positive monkeys but not in the lower lobes. No significant changes were observed in individual lobes of SHIV/Pc-negative monkeys ( Figure 3B) .
Consistent with an increase in the percentage of emphysematous tissue, total tissue volume and lung weight were significantly decreased from baseline in SHIV/Pc-positive monkeys (Table 2) but not in SHIV/Pc-negative monkeys. No significant changes in small-airway wall dimensions, including thickness, were observed for either group (not shown). Airspace enlargement was also evaluated in lung tissue sections by determination of mean chord length, the average distance between opposing walls of a single alveolus. Figure 3C shows representative lung tissue sections from both groups. In support of our radiologic findings, mean chord length was significantly larger in monkeys with obstruction than in monkeys without obstruction ( Figure 3D ).
Pc colonization results in increased bronchial-associated lymphoid tissue in SHIV-infected monkeys. As an indicator of inflammation due to increased pathogen burden, lung tissue was examined for the presence of bronchial-associated lymphoid tissue. SHIV/Pc-positive monkeys had a significantly higher frequency of bronchial-associated lymphoid tissue, compared with SHIV/Pc-monkeys, indicating persistent pulmonary inflammation in these animals ( Figure 4A and 4B) .
Pc colonization induces inflammatory and Th2-associated cytokines in the BALF of SHIV-infected monkeys. Because COPD and PcP have been associated with vigorous inflammatory responses [24, 25] , we evaluated inflammation indicators in serial BALF samples after SHIV infection and Pc colonization. Interestingly, there were no significant changes in the absolute number or percentage of T cells, macrophages, neutrophils, or CD4 + /CD8 + T cell ratios in the BALF of infected monkeys, regardless of Pc status (up to 12 months after SHIV infection) (not shown). Serial cytokine and chemokine analysis of BALF revealed changes from baseline in SHIV/Pc-positive, but not SHIV/Pc-negative, monkeys (Table 1) . Assays were performed at baseline, 4 weeks after SHIV infection (after a significant decrease in CD4 + T cells but before detectable Pc colonization), and at weeks 16 and 35 (after detection of persistent Pc colonization). At weeks 16 and 35, increases in interleukin (IL)-4, IL-5, IL-6, granulocyte-macrophage-colony stimulating factor (GM-CSF), and lymphotoxin-a and transient increases in IL-8, IL-13, interferon (IFN)-g, macrophage inflammatory protein (MIP)-1a, and tumor necrosis factor (TNF)-a were observed in SHIV/Pc-positive monkeys. Conversely, SHIV/Pcnegative animals did not exhibit increases in cytokine levels, except for TNF-a at 35 weeks. These results demonstrate that SHIV infection alone had little effect on induction of inflammatory mediators in alveolar spaces, whereas Pc colonization induced a proinflammatory and Th2-skewed cytokine response, which was coincident with decreasing pulmonary function (Figure 2) .
DISCUSSION
The results presented here support the concept that Pc colonization contributes to the development of COPD in a nonhuman primate model of HIV infection. SHIV-infected monkeys that became naturally colonized with Pc developed progressive pulmonary obstruction that was unresponsive to bronchodilator treatment. In addition, Pc colonization correlated with anatomical evidence of emphysema, increased bronchialassociated lymphoid tissue frequency, and increased levels of proinflammatory mediators and Th2-type cytokines in BALF. In contrast, SHIV infection alone did not exert such effects. These data support the hypothesis that, in HIV-associated COPD, persistent Pc carriage, which is common among HIVpositive subjects [8, 9] , induces lung inflammation, possibly promoting tissue damage and COPD development.
COPD is a complex disorder resulting from a combination of genetic and environmental factors associated with persistent lung inflammation [25] . Although cigarette smoking is the main risk factor, other factors likely influence disease progression, because only ∼25% of smokers develop COPD [26] . HIV infection is also associated with an increased COPD risk, particularly in smokers. Diaz et al [2] reported that 37% of HIVinfected smokers had emphysema, as determined by a pulmonary function test or chest computed tomography scan, in contrast to no HIV-negative controls having demonstrable emphysema. Crothers et al [3] showed that HIV-positive subjects are more likely to have a COPD diagnosis, compared with HIVnegative controls, and that HIV infection was an independent predictor of COPD. Reports of a high frequency of Pc colonization in HIV-infected subjects and HIV-negative patients with COPD [7, 27] suggest that persistent Pc carriage may promote a decrease in pulmonary function and COPD devel- , by paired t test, for the proportion of lung tissue that is emphysematous in P p .04 both the upper and middle lobes for baseline vs. end point scans;
, by paired t test, for the proportion of lung tissue that is emphysematous P p .78 in the lower lobe in baseline vs. end point scans (
). For SHIV/Pc-negative animals: , , and , by paired t test for the n p 6 P p .55 P p .80 P p .11 proportion of lung tissue that is emphysematous in the upper, middle, and lower lobes, respectively, in baseline vs. end point scans (
). C, n p 4 Representative hematoxylin-stained lung tissue sections from SHIV-infected monkeys; left, SHIV/Pc negative; right, SHIV/Pc positive. D, Chord length analysis (mean ‫ע‬ standard error of the mean) of airspaces for animals exhibiting clinical type (у12% decrease in pulmonary function from the baseline level) obstruction (COPD positive; ) vs. nonobstructed animals (COPD negative; ), * . Note: Two SHIV/Pc-positive animals n p 5 n p 7 P ! .001 were not included in either the preinfection or postinfection analyses, because baseline scans were not performed. Both of these animals developed airway obstruction based on pulmonary function testing. opment. The primate model of HIV infection described in the present study supports these clinical findings and enables longitudinal characterization of factors associated with the development of COPD pathogenesis.
SIV and SHIV have been used extensively in rhesus and cynomolgus macaques as models of HIV [28] . As in HIV infection, PcP is common in SIV-infected and SHIV-infected macaques, and susceptibility correlates with a decrease in peripheral blood CD4 + T cells [15, 29] . In contrast to SIV, SHIV produces a rapid decrease in blood CD4 + T cells, facilitating longterm studies of persistent infection. We previously described SIV infection/Pc colonization in macaques, by use of both intrabronchial inoculation and airborne transmission of Pc [12, 16] . Airborne transmission is more likely representative of natural Pc transmission and eliminates the potential transient inflammatory responses associated with intrabronchial inoculations [12] , allowing examination of inflammatory responses associated with persistent colonization.
In serial pulmonary function studies, we found significant obstruction in 6 of 8 Pc-colonized monkeys, but not in monkeys infected with SHIV alone. These data suggest that viral infection is insufficient to induce emphysema, but SHIV-induced immunosuppression may increase Pc carriage susceptibility, which may result in obstructive changes. Interestingly, one SHIV/Pc-positive monkey without a measurable decrease in pulmonary function showed evidence of emphysema based on increased lung volume and the percentage of lung tissue рϪ910 HU (not shown). This finding suggests that SHIV infection and Pc colonization may result in emphysema without airflow obstruction, a COPD phenotype described in humans [30] . No significant changes between baseline and end point small-airway wall dimensions were observed in either group, suggesting that the observed pulmonary obstruction was an emphysema-dominant phenotype with minimal small airway involvement [31] .
Several studies have examined inflammatory responses in patients with COPD, with conflicting results likely the result of disease heterogeneity, variability in disease severity, and lung region sampling differences [32, 33] . Neutrophils have been implicated in COPD pathogenesis. Patients with severe COPD have neutrophilic infiltration of airway walls and increased neutrophil counts in BALF and sputum samples that correlate with disease severity [34, 35] . In contrast, mild emphysema is not commonly associated with BAL neutrophilia [36] . Similarly, studies have shown T cell infiltration in the small-airway walls and alveolar spaces of patients with COPD with general increases in CD8 + T cell proportions, although their role in COPD-associated inflammatory damage is unknown. CD4 + and CD8 + T cells can elaborate proinflammatory cytokines that may contribute to lung damage. Th1-skewed cytokine production has been reported in patients with COPD in several studies [37] , although a mixed or Th2-dominant response has also been reported [38] .
We detected inflammatory changes in airspaces only after Pc colonization was evident, with there being little evidence of inflammation due to persistent SHIV infection. Increases in IL-4, IL-5, and IL-13 with minimal increases in IFN-g and no detectable IL-12 in SHIV/Pc-positive monkeys suggested a Th2-skewed response. Although Th2 cytokines are more commonly associated with asthma [39] , these results support reports of increased IL-4 in emphysematous human lung tissue [40] . In addition, Ma et al [41] demonstrated that, in mice genetically predisposed toward a Th1 response, overexpression of IL-4 resulted in emphysematous pulmonary destruction and reduced protease inhibitor levels in the lung.
The increased IL-13 observed in Pc-colonized monkeys is interesting in light of reports that emphysema was associated with IL-13 expression in a transgenic mouse model [42] and in murine models of Nippostrongylus brasiliensis [43] and persistent viral infection [44] . Although its role in alveolar destruction progression is unclear, increased IL-13 in transgenic mice correlated with increased matrix metalloprotease and cathepsin production in lung tissue [22] , which may promote lung tissue degradation in emphysema [45] . IL-1b, IL-6, and GM-CSF-proinflammatory cytokines associated with macrophage activation-were also increased in the BALF of SHIV/Pc-positive monkeys. These results are consistent with reports of increased levels of these cytokines in pulmonary and plasma samples from patients with COPD [46] and in animal models of emphysema [47] , indicating a key role for macrophage activation in the early process of lung damage in this model.
Contrary to studies reporting inflammatory cellular infiltration associated with human and animal COPD, we found no significant changes in the absolute numbers or proportions of T cells or neutrophils in the BALF of either monkey group, even after significant pulmonary function decline was evident. This may be the result of the fact that, in human studies, patients have had clinical disease for years, whereas the primate model is capturing early events in disease progression. Unlike our previous study showing infiltration of CD8 + T cells and neutrophils in intrabronchially infected macaques [12] , the Pc doses associated with natural colonization reported here were likely much lower. It is likely that, as Pc burden increases, a CD8 + T cell-and neutrophil-dominant response may develop and amplify inflammation-mediated pulmonary damage.
Innate inflammatory responses initiated by alveolar macrophages or other cells, such as mast cells, natural killer cells, or natural killer T cells, may be activated early in response to Pc colonization, thus elaborating proinflammatory cytokines before detectable activation of adaptive responses and subsequent cellular infiltration. This hypothesis is consistent with studies suggesting that macrophages and NKT cells are key effectors in murine models demonstrating IL-13-mediated emphysematous destruction [43, 44] . In addition, a role for mast cells in human COPD has been suggested [48] , possibly via IL-4 upregulation 49]. We further postulate that persistent Pc colonization is associated with an adaptive immune response, as indicated by increased frequency of bronchial-associated lymphoid tissue in Pc-colonized monkeys with COPD. These results are consistent with the finding of an increased frequency of bronchial-associated lymphoid tissue in patients with COPD, and they support the concept that persistent infection and host immune response are associated with COPD development [4, 35] .
This study establishes a novel model for HIV-associated COPD and provides evidence supporting a role for Pc colonization in obstructive disease development. These results support the paradigm that infectious agents, directly or indirectly, can promote COPD pathogenesis [4, 43] . A detrimental inflammatory response may be amplified by continuous or repeated colonization by various pulmonary pathogens leading to disease progression, as has been clinically shown [50] . As in human COPD pathogenesis, it is likely that COPD development in SHIV-infected macaques is multifactorial and that genetic and environmental factors contribute to susceptibility. This study supports the concept that Pc colonization contributes to COPD pathogenesis in SHIV-infected macaques but does not exclude a role for other factors. The nonhuman primate model allows for serial examination of various parameters associated with development of obstructive changes and should help define host responses that promote tissue destruction at early disease stages. In addition, these results identify Pc as a potentially treatable risk factor for COPD development in HIV-infected and -noninfected individuals.
